Leibniz-institut Fur Polymerforschung Dresden E.v.

Denovomatrix Gmbh

Zetascience Gmbh

Facellitate Gmbh

Technische Universitát Dresden

Deutsches Zentrum Fur Neurodegenerative Erkrankungen E. V.

Tissueguard Gmbh

Klinikum Chemnitz Ggmbh

Carsten Werner

Uwe Freudenberg

Mikhail Tsurkan

Yixin Zhang

Robert Wieduwild

Francesco Reddavide

Veronique Schwartz

Valentina Magno

Michael Seufert

Lars David Renner

Heather Weber

Petra Welzel

Marie-Francoise Gouzy

Dorit Meinhold

Marle-Francoise Gouzy

Uwe Streller

Claudia Sperling

Katrin Salchert

Frank Böhme

Katrin Engelmann

Marina Prewitz

Heinz Körber

Juliane Bessert

Christos Papadimitriou

Michael Thompson

Caghan Kizil

Helena Andrade

Passant Atallah

Device D for cultivating cell cultures C, wherein said device D has a surface O and comprises on its surface O at least one polymer P wherein said polymer P is a copolymer of at least one monomer M and at least one ester E of (meth)acrylic acid and polyethylene oxide, wherein said monomer M is different from ester E and has at least one ethylenically unsaturated double bond.

Devices for cultivating cells coated with a copolymer of polyethyleneglykol (meth)acrylate

The invention relates to a method for the formation of renal tubules by embedding individual renal cells into a synthetic hydrogel, which is based on polyethylene glycol as a component, and the culturing of the cells until tubule structures are formed. The culturing can be continued until the obtained tubule structures correspond in terms of size, structure, morphology and functionality to adult human renal tubules or are at least similar thereto.

Method for the formation of renal tubules

The invention relates to a hydrogel matrix comprising a mixture of a covalent peptide-polymer conjugate and an oligosaccharide;

Non-covalent, self-organzing hydrogel matrix for biotechnological applications

The invention relates to a bioactive hydrogel as a hybrid material of heparin and star-branched polyethylene glycol with functionalized end groups, wherein the heparin is bound directly by reaction of the carboxyl groups activated with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimides/N-hydroxysulfosuccinimide (EDC/s-NHS) with the terminal amino groups of the polyethylene glycol covalently by amide bonds.

Bioactive hydrogel

Growing community of inventors

Dresden, Germany

Carsten Werner